Frederique Menzaghi Ph.D., Chief Scientific Officer, SVP-R&D at Cara Therapeutics, Inc. (CARA), sold 20,000 shares at $17.50 ($373K) on 2019-03-12, disclosed to the SEC on 2019-03-14.
Open-market sale of $373k CARA by Chief Scientific Officer, SVP-R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.50 | 3,197 | $56K | 15.0% |
| 2 | $18.87 | 16,803 | $317K | 85.0% |
| Total | $18.65 avg | 20,000 | $373K | 100% |
| Filing → |
| CARA | SELL | 2023-03-07 | $132K | — | Filing → |
| CARA | SELL | 2022-12-23 | $40K | — | Filing → |
| CARA | SELL | 2022-04-05 | $21K | — | Filing → |